Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2012.05.31
中国中投证券有限责任公司关于公司拟以超募资金受让子公司股权有关事项的核查意见
2012.05.31
关于使用超额募集资金受让控股子公司部分股权的公告
2012.05.31
第二届监事会第十四次会议决议公告
2012.05.31
第二届董事会第十五次会议决议公告
2012.05.17
关于股票期权授予登记完成的公告
2012.05.03
关于向控股子公司提供委托贷款的进展公告
2012.05.03
2011年度权益分派实施公告
2012.05.03
关于收到控股子公司归还委托贷款的公告
2012.04.26
内部控制审计报告
2012.04.26
关于股票期权激励计划授予相关事项公告
第一页
上一页
134
135
136
137
138
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
